Erik Halvorsen , PhD
Erik Halvorsen became the Director of Technology and Business Development for Children's Hospital Boston in September of 2007. He oversees and manages the Technology and Innovation Development Office (TIDO) responsible for translating Children's renowned laboratory and clinical research into devices, therapeutics, diagnostics, and informatics products that can benefit patients around the world. Prior to joining Children's Hospital, Erik was the Director of Business Development at Harvard University's Office of Technology Development. He joined Harvard in 2002 where he was primarily responsible for the patenting and licensing of technology arising from the departments of Molecular & Cellular Biology and Chemistry & Chemical Biology including early stage therapeutics, stem cells, targets and drug discovery technology. In 2006, Erik also became the first Director of Business Development for the Harvard Stem Cell Institute (HSCI). There he developed a comprehensive stem cell intellectual property (IP) policy, ratified and enacted by HSCI affiliated institutions, which allowed for centralization of stem cell IP and returned a portion of license revenue to fund additional stem cell research. Prior to joining Harvard, Erik worked at the University of Virginia (UVA) Patent Foundation and the UVA Patent Foundation for-profit subsidiary, Spinner Technologies Inc. There he worked as a case manager starting up companies with faculty members around university technologies. His PhD in Neuropharmacology focused on elucidating apoptotic and anti-apoptotic intracellular signaling pathways activated in Parkinson's disease and identifying potential therapeutic targets to slow or inhibit neuronal cell death and has authored and co-authored several peer reviewed papers. Erik also holds an M.S. from the Medical College of Virginia and a B.A. from the University of Virginia.
Children's Hospital BostonTechnology and Business Development300 Longwood AvenueBK120Boston, MA 02115Phone: 617-919-3026